🎉 M&A multiples are live!
Check it out!

Avacta Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for Avacta Group and similar public comparables like Armata Pharmaceuticals, Julphar, and Galapagos.

Avacta Group Overview

About Avacta Group

Avacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation protein or FAP) that is designed to concentrate potent warheads in the tumor microenvironment while sparing normal tissues. The company's pipeline consists of pre-CISION peptide drug conjugates (PDC) or Affimer drug conjugates (AffDC) that leverage the tumor-specific release mechanism, providing benefits over traditional antibody drug conjugates. The firm has one reportable segment, Therapeutics, which is engaged in the development of novel cancer therapies harnessing its proprietary technology. Geographically, it derives revenue from South Korea.


Founded

2003

HQ

United Kingdom of Great Britain and Northern Ireland
Employees

151

Website

avacta.com

Financials

LTM Revenue $1.7M

LTM EBITDA -$32.1M

EV

$386M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Avacta Group Financials

As of September 2025, Avacta Group reported last 12-month revenue of $1.7M and EBITDA of -$32.1M.

In the same period, Avacta Group generated -$0.2M in LTM gross profit and -$39.8M in net income.

See Avacta Group valuation multiples based on analyst estimates

Avacta Group P&L

In the most recent fiscal year, Avacta Group reported revenue of $0.2M and EBITDA of -$23.5M.

Avacta Group expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Avacta Group valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $1.7M XXX $0.2M XXX XXX XXX
Gross Profit -$0.2M XXX $0.2M XXX XXX XXX
Gross Margin -12% XXX 100% XXX XXX XXX
EBITDA -$32.1M XXX -$23.5M XXX XXX XXX
EBITDA Margin -1845% XXX -15596% XXX XXX XXX
EBIT -$36.2M XXX -$42.4M XXX XXX XXX
EBIT Margin -2079% XXX -28151% XXX XXX XXX
Net Profit -$39.8M XXX -$70.4M XXX XXX XXX
Net Margin -2283% XXX -46762% XXX XXX XXX
Net Debt XXX XXX $10.2M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Avacta Group Stock Performance

Avacta Group has current market cap of GBP 282M (or $376M), and EV of GBP 289M (or $386M).

Market Cap Evolution

Avacta Group Stock Data

As of October 17, 2025, Avacta Group's stock price is GBP 1 (or $1).

See Avacta Group trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$386M $376M XXX XXX XXX XXX $-0.09

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Avacta Group Valuation Multiples

Avacta Group's trades at 2559.2x EV/Revenue multiple, and -16.4x EV/EBITDA.

See valuation multiples for Avacta Group and 15K+ public comps

Avacta Group Financial Valuation Multiples

As of October 17, 2025, Avacta Group has market cap of $376M and EV of $386M.

Equity research analysts estimate Avacta Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Avacta Group has a P/E ratio of -9.4x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $376M XXX $376M XXX XXX XXX
EV (current) $386M XXX $386M XXX XXX XXX
EV/Revenue 221.4x XXX 2559.2x XXX XXX XXX
EV/EBITDA -12.0x XXX -16.4x XXX XXX XXX
EV/EBIT -10.6x XXX -9.1x XXX XXX XXX
EV/Gross Profit -1804.4x XXX n/a XXX XXX XXX
P/E -9.4x XXX -5.3x XXX XXX XXX
EV/FCF -8.1x XXX -12.1x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Avacta Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Avacta Group Margins & Growth Rates

Avacta Group's last 12 month revenue growth is -75%

Avacta Group's revenue per employee in the last FY averaged $1K, while opex per employee averaged $0.3M for the same period.

Avacta Group's rule of 40 is -114% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Avacta Group's rule of X is -2034% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Avacta Group and other 15K+ public comps

Avacta Group Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth -75% XXX n/a XXX XXX XXX
EBITDA Margin -1845% XXX -15596% XXX XXX XXX
EBITDA Growth 0% XXX n/a XXX XXX XXX
Rule of 40 -114% XXX -15672% XXX XXX XXX
Bessemer Rule of X XXX XXX -2034% XXX XXX XXX
Revenue per Employee XXX XXX $1K XXX XXX XXX
Opex per Employee XXX XXX $0.3M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 10660% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 12625% XXX XXX XXX
Opex to Revenue XXX XXX 28251% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Avacta Group Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Pharma Diagnostics & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Avacta Group M&A and Investment Activity

Avacta Group acquired  XXX companies to date.

Last acquisition by Avacta Group was  XXXXXXXX, XXXXX XXXXX XXXXXX . Avacta Group acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Avacta Group

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Avacta Group

When was Avacta Group founded? Avacta Group was founded in 2003.
Where is Avacta Group headquartered? Avacta Group is headquartered in United Kingdom of Great Britain and Northern Ireland.
How many employees does Avacta Group have? As of today, Avacta Group has 151 employees.
Who is the CEO of Avacta Group? Avacta Group's CEO is Dr. Christina Marie Coughlin.
Is Avacta Group publicy listed? Yes, Avacta Group is a public company listed on LON.
What is the stock symbol of Avacta Group? Avacta Group trades under AVCT ticker.
When did Avacta Group go public? Avacta Group went public in 2003.
Who are competitors of Avacta Group? Similar companies to Avacta Group include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Avacta Group? Avacta Group's current market cap is $376M
What is the current revenue of Avacta Group? Avacta Group's last 12 months revenue is $1.7M.
What is the current revenue growth of Avacta Group? Avacta Group revenue growth (NTM/LTM) is -75%.
What is the current EV/Revenue multiple of Avacta Group? Current revenue multiple of Avacta Group is 221.4x.
Is Avacta Group profitable? Yes, Avacta Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Avacta Group? Avacta Group's last 12 months EBITDA is -$32.1M.
What is Avacta Group's EBITDA margin? Avacta Group's last 12 months EBITDA margin is -1845%.
What is the current EV/EBITDA multiple of Avacta Group? Current EBITDA multiple of Avacta Group is -12.0x.
What is the current FCF of Avacta Group? Avacta Group's last 12 months FCF is -$47.5M.
What is Avacta Group's FCF margin? Avacta Group's last 12 months FCF margin is -2726%.
What is the current EV/FCF multiple of Avacta Group? Current FCF multiple of Avacta Group is -8.1x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.